Oncology and Hematology

481-496 of 612

Managing Immunotherapy Toxicities in Lung Cancer Patients
Managing Immunotherapy Toxicities in Lung Cancer Patients
Project Oncology®
Managing Immunotherapy Toxicities in Lung Cancer Patients
- Jacob Sands, MD
- Aliyah Pabani, MD
Exploring the Role of Biomarkers in Lung Cancer Treatment
Exploring the Role of Biomarkers in Lung Cancer Treatment
Project Oncology®
Exploring the Role of Biomarkers in Lung Cancer Treatment
- Jacob Sands, MD
- Biagio Ricciuti, MD
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Project Oncology®
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
- Pavani Chalasani, MD, MPH
- Hope S. Rugo, MD, FASCO
Recognizing the Role of Capmatinib for METex14 in NSCLC
Recognizing the Role of Capmatinib for METex14 in NSCLC
Project Oncology®
Recognizing the Role of Capmatinib for METex14 in NSCLC
- Jacob Sands, MD
- Edward B. Garon, MD, MS
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Project Oncology®
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
- Pavani Chalasani, MD, MPH
- Prof. David Cameron
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Project Oncology®
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
- Pavani Chalasani, MD, MPH
- Erika Hamilton, MD
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Project Oncology®
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
- Pavani Chalasani, MD, MPH
- Kevin Kalinsky MD, MS
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Project Oncology®
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
- Pavani Chalasani, MD, MPH
- Nan Chen, MD
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
Project Oncology®
Treating Metastatic Breast Cancer: Where Are We Now?
- Pavani Chalasani, MD, MPH
- Seema A. Khan, MD
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Project Oncology®
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
- Jacob Sands, MD
- Maya Leiva, PharmD, BCOP
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Project Oncology®
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
- Jacob Sands, MD
- Maya Leiva, PharmD, BCOP
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
- Pavani Chalasani, MD, MPH
- Kevin Kalinsky MD, MS
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
Project Oncology®
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
- Pavani Chalasani, MD, MPH
- Aditya Bardia, MD, MPH
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Project Oncology®
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
- Pavani Chalasani, MD, MPH
- Aditya Bardia, MD, MPH
Research Shows Overdiagnosis of Melanoma in White Men & Women
Research Shows Overdiagnosis of Melanoma in White Men & Women
DermConsult
Research Shows Overdiagnosis of Melanoma in White Men & Women
A Look at HIV & Its Link to Cancer
A Look at HIV & Its Link to Cancer
Global Oncology Academy
A Look at HIV & Its Link to Cancer